AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
about
Ceftaroline fosamil: a brief clinical review.Levofloxacin-resistant haemophilus influenzae, Taiwan, 2004-2010.Effectiveness of azithromycin in aspiration pneumonia: a prospective observational studyClinical importance and epidemiology of quinolone resistance.Nasopharyngeal carriage and antimicrobial susceptibility of Haemophilus influenzae among children younger than 5 years of age in Beijing, ChinaStreptococcus pneumoniae and Haemophilus influenzae in paediatric meningitis patients at Goroka General Hospital, Papua New Guinea: serotype distribution and antimicrobial susceptibility in the pre-vaccine era.The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013.Proteasome β5i Subunit Deficiency Affects Opsonin Synthesis and Aggravates Pneumococcal PneumoniaComparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.Molecular epidemiology of pneumococcal isolates from children in China.Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey.Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in TurkeyEffect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary DiseaseFluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.The changing microbiologic epidemiology of community-acquired pneumonia.Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamil.Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia.The role of solithromycin in the management of bacterial community-acquired pneumonia.Antimicrobial susceptibility of bacterial isolates from patients presenting with ear, nose and throat (ENT) infections in the German community healthcare setting.Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.Solithromycin for the treatment of community-acquired bacterial pneumonia.Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers.Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.In Vitro Activities of Ceftaroline and Comparators against Streptococcus pneumoniae Isolates from U.S. Hospitals: Results from Seven Years of the AWARE Surveillance Program (2010 to 2016).Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults
P2860
Q33939080-02CD5F45-175A-4966-90F6-AEAE0EC9B2C1Q33951148-BC86F15E-086B-4C9A-A13E-4500F969ECC1Q34695463-58E7B437-6B83-4248-B7AD-FCEA4A4DFE74Q34838791-7D83BA8D-9198-41D9-BF57-FA13B17FCBEAQ35094725-17493A2A-57FC-43AD-8720-D38A7569643FQ35828587-A83671FF-CEBB-492F-9C16-E1D965E0F6C1Q35841832-95C6B47F-9B81-407A-BF30-2854E679C083Q35995706-FE2A9F97-1C66-4D37-BF9F-98D6B7EB5FEFQ36195774-9E27B091-4FD8-4F8A-A344-57E572219203Q36854394-C206DC05-A373-4593-AB0E-87EB070E4312Q36960322-35726C5B-FC3D-4921-9477-12E6E29F7AECQ36960348-89B011C3-DD1D-4767-A7BF-4A9CD625AFE5Q37023332-630B7A63-8617-4EC1-A13C-A12CBD3D8082Q37661000-A25379A5-E109-4D4E-AE22-80B72C67DF03Q38117077-51A0BC94-183F-43FF-B2BF-FB7696A33F43Q38160635-E8C9929F-E6FB-4292-BD64-4993014F711BQ38262950-034BD605-4125-489A-86A0-EE4BF9D9B7F6Q38286351-1EFB5D48-77B5-4183-A927-C3CD9C484633Q38601840-A15C9052-16A5-47A5-9837-47D32509A520Q38723961-0E12BD07-6CB2-4CF4-A392-9A0087B56068Q38827462-60625A00-FE2E-48DB-9478-62A0F37F1E6DQ39157514-E0172330-F115-49F3-9BFB-9D05D027195AQ39278428-3FB54F4E-1CC0-406C-9CBE-6CC0354760D9Q39502727-E3DE6419-A73F-4593-9B4F-CF66DD6461AEQ39682573-A790AE0C-FA5D-44E7-BE6D-F2ABA7DE6E89Q47689257-1120E664-162E-429A-BA07-A088DF5124A0Q47705232-8CD35662-C94C-48CF-BC4C-82FB3ABEF5C9Q58617498-A7406E26-728C-4373-9202-0A7608AA83D9
P2860
AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
AWARE Ceftaroline Surveillance ...... arrhalis in the United States.
@en
AWARE Ceftaroline Surveillance ...... arrhalis in the United States.
@nl
type
label
AWARE Ceftaroline Surveillance ...... arrhalis in the United States.
@en
AWARE Ceftaroline Surveillance ...... arrhalis in the United States.
@nl
prefLabel
AWARE Ceftaroline Surveillance ...... arrhalis in the United States.
@en
AWARE Ceftaroline Surveillance ...... arrhalis in the United States.
@nl
P2860
P356
P1476
AWARE Ceftaroline Surveillance ...... arrhalis in the United States.
@en
P2093
David J Farrell
Ronald N Jones
P2860
P304
P356
10.1093/CID/CIS561
P407
P478
55 Suppl 3
P577
2012-09-01T00:00:00Z